Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2010Open Access

recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJosef S SmolenMedical University of ViennaRLRobert LandewéUniversità Cattolica del Sacro CuoreFBFerdinand C. BreedveldLeiden University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Smolen et al. (2010) studied this question.

synapsesocial.com/papers/69d8cd73ce048d2571bee366https://doi.org/10.1136/ard.2009.126532
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy of Methotrexate in Rheumatoid Arthritis1995 · 53 citations
  2. 2Systematic Review: Comparative Effectiveness and Harms of Disease-Modifying Medications for Rheumatoid Arthritis2008 · 299 citations
  3. 3Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial2006 · 439 citations